113 related articles for article (PubMed ID: 15830915)
21. Plasma and urine pharmacokinetics of free and of short-chain carnitine after administration of carnitine in man.
Segre G; Bianchi E; Corsi M; D'Iddio S; Ghirardi O; Maccari F
Arzneimittelforschung; 1988 Dec; 38(12):1830-4. PubMed ID: 3245856
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of IV and oral acetyl-L-carnitine in a multiple dose regimen in patients with senile dementia of Alzheimer type.
Parnetti L; Gaiti A; Mecocci P; Cadini D; Senin U
Eur J Clin Pharmacol; 1992; 42(1):89-93. PubMed ID: 1541322
[TBL] [Abstract][Full Text] [Related]
23. Intravenous L-carnitine and acetyl-L-carnitine in medium-chain acyl-coenzyme A dehydrogenase deficiency and isovaleric acidemia.
Van Hove JL; Kahler SG; Millington DS; Roe DS; Chace DH; Heales SJ; Roe CR
Pediatr Res; 1994 Jan; 35(1):96-101. PubMed ID: 8134205
[TBL] [Abstract][Full Text] [Related]
24. Effect of L-carnitine administration on the seminal characteristics of oligoasthenospermic stallions.
Stradaioli G; Sylla L; Zelli R; Chiodi P; Monaci M
Theriogenology; 2004 Aug; 62(3-4):761-77. PubMed ID: 15226028
[TBL] [Abstract][Full Text] [Related]
25. [Influence of multiple-dose administration of cefetamet pivoxil on blood and urinary concentrations of carnitine and effects of simultaneous administration of carnitine with cefetamet pivoxil].
Nakashima M; Kosuge K; Ishii I; Ohtsubo M
Jpn J Antibiot; 1996 Oct; 49(10):966-79. PubMed ID: 8986559
[TBL] [Abstract][Full Text] [Related]
26. Protein binding of L-carnitine family components.
Marzo A; Arrigoni Martelli E; Mancinelli A; Cardace G; Corbelletta C; Bassani E; Solbiati M
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():364-8. PubMed ID: 1820909
[TBL] [Abstract][Full Text] [Related]
27. Disposition and metabolite kinetics of oral L-carnitine in humans.
Bain MA; Milne RW; Evans AM
J Clin Pharmacol; 2006 Oct; 46(10):1163-70. PubMed ID: 16988205
[TBL] [Abstract][Full Text] [Related]
28. Indications that topical L-carnitin-L-tartrate promotes human hair growth in vivo.
Foitzik K; Hoting E; Heinrich U; Tronnier H; Paus R
J Dermatol Sci; 2007 Nov; 48(2):141-4. PubMed ID: 17804203
[No Abstract] [Full Text] [Related]
29. Changes in hepatic lipogenic and oxidative enzymes and glucose homeostasis induced by an acetyl-L-carnitine and nicotinamide treatment in dyslipidaemic insulin-resistant rats.
Ferreira MR; Camberos Mdel C; Selenscig D; Martucci LC; Chicco A; Lombardo YB; Cresto JC
Clin Exp Pharmacol Physiol; 2013 Mar; 40(3):205-11. PubMed ID: 23278446
[TBL] [Abstract][Full Text] [Related]
30. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
31. Plasma pharmacokinetics and gastrointestinal transit of a new propionyl-L-carnitine controlled release formulation.
Wagner CC; Rusca A; Kletter K; Tschurlovits M; Pace S; Longo A; Pedrani M; Villa R; Frimonti E; Müller M; Brunner M
Xenobiotica; 2011 Nov; 41(11):988-95. PubMed ID: 21810044
[TBL] [Abstract][Full Text] [Related]
32. Determination of the reference range of endogenous plasma carnitines in healthy adults.
Reuter SE; Evans AM; Chace DH; Fornasini G
Ann Clin Biochem; 2008 Nov; 45(Pt 6):585-92. PubMed ID: 18782814
[TBL] [Abstract][Full Text] [Related]
33. [Experiences with L-carnitine in the post-stress phase].
Balogh D; Hackl JM; Legenstein E; Musil HE
Infusionsther Klin Ernahr; 1986 Oct; 13(5):204-8. PubMed ID: 3100446
[TBL] [Abstract][Full Text] [Related]
34. [L-carnitine as a basis of cholinomimetic substances].
Strack E; Seim H
Acta Biol Med Ger; 1976; 35(5):645-56. PubMed ID: 1086568
[TBL] [Abstract][Full Text] [Related]
35. The effect of oral L-carnitine supplementation on the muscle and plasma concentrations in the Thoroughbred horse.
Foster CV; Harris RC; Snow DH
Comp Biochem Physiol A Comp Physiol; 1988; 91(4):827-35. PubMed ID: 2907450
[TBL] [Abstract][Full Text] [Related]
36. Effect of acetyl-L-carnitine treatment on the levels of levocarnitine and its derivatives in streptozotocin-diabetic rats.
Marzo A; Corsico N; Cardace G; Morabito E
Arzneimittelforschung; 1993 Mar; 43(3):339-42. PubMed ID: 8489564
[TBL] [Abstract][Full Text] [Related]
37. Studies on the degenerative and regenerative phenomena occurring after transection and repair of the sciatic nerve in rats: effects of acetyl-L-carnitine.
Fernandez E; Pallini R; Gangitano C; Del Fa A; Olivieri-Sangiacomo C; Sbriccoli A; Ricoy J; Rossi GF
Int J Clin Pharmacol Res; 1990; 10(1-2):85-99. PubMed ID: 2387666
[TBL] [Abstract][Full Text] [Related]
38. Effects of L-carnitine supplementation to suckling piglets on carcass and meat quality at market age.
Lösel D; Rehfeldt C
Animal; 2013 Jul; 7(7):1191-8. PubMed ID: 23473237
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of oral acetyl-L-carnitine in renal impairment.
Kelly JG; Hunt S; Doyle GD; Laher MS; Carmody M; Marzo A; Arrigoni Martelli E
Eur J Clin Pharmacol; 1990; 38(3):309-12. PubMed ID: 2340852
[TBL] [Abstract][Full Text] [Related]
40. L-carnitine and carnitine ester transport in the rat small intestine.
Marciani P; Lindi C; Marzo A; Arrigoni Martelli E; Cardace G; Esposito G
Pharmacol Res; 1991 Feb; 23(2):157-62. PubMed ID: 2062791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
